GUIDOBONI, Massimo
GUIDOBONI, Massimo
Dipartimento di Medicina Traslazionale e per la Romagna
Activation of infiltrating cytotoxic T lymphocytes and lymphoma cell apoptotic rates in gastric MALT lymphomas - Differences between high-grade and low-grade cases
file con accesso da definire1999 Guidoboni, M; Doglioni, C; Laurino, L; Boiocchi, M; Dolcetti, R
Anti-PD1 antibodies in patients aged ≥ 75 years with metastatic melanoma: A retrospective multicentre study
2020 Ridolfi, L; de Rosa, F; Petracci, E; Tanda, Et; Marra, E; Pigozzo, J; Marconcini, R; Guida, M; Cappellini, Gca; Gallizzi, G; Occelli, M; Pala, L; Gambale, E; Bersanelli, M; Galdo, G; Cortellini, A; Morgese, F; Zoratto, F; Stucci, Ls; Strippoli, S; Guidoboni, M
Appropriate use of tumour biomarkers for treatment with innovative drugs: A retrospective study
file con accesso da definire2016 Massa, I; Nanni, O; Guidoboni, M; Frassineti, Gl; Rocca, A; Burgio, Ma; Valmorri, L; Marri, M; Piancastelli, A; Faedi, M; Leoni, M; Tamberi, S; Altini, M; Amadori, D
Association between Helicobacter pylori infection and MALT-type lymphoma of the ocular adnexa: clinical and therapeutic implications
file con accesso da definire2006 Ferreri, Aj; Ponzoni, M; Viale, E; Guidoboni, M; De Conciliis, C; Resti, Ag; Politi, L; Lettini, Aa; Sacchetti, F; Dognini, G; Dolcetti, R; Doglioni, C
Association of CTLA-4 Gene Variants with Response to Therapy and Long-term Survival in Metastatic Melanoma Patients Treated with Ipilimumab: An Italian Melanoma Intergroup Study
file con accesso da definire2017 Queirolo, P; Dozin, B; Morabito, A; Banelli, B; Piccioli, P; Fava, C; Leo, C; Carosio, R; Laurent, S; Fontana, V; Ferrucci, Pf; Martinoli, C; Cocorocchio, E; Battaglia, A; Ascierto, Pa; Capone, M; Simeone, E; De Galitiis, F; Pagani, E; Cappellini, Gca; Marchetti, P; Guida, M; Tommasi, S; Mandala, M; Merelli, B; Quaglino, P; Fava, P; Guidoboni, M; Romani, M; Spagnolo, F; Pistillo, Mp
Bacteria-eradicating therapy with doxycycline in ocular adnexal MALT lymphoma: A multicenter prospective trial
file con accesso da definire2006 Ferreri, Ajm; Ponzoni, M; Guidoboni, M; Resti, Ag; Politi, Ls; Cortelazzo, S; Demeter, J; Zallio, F; Palmas, A; Muti, G; Dognini, Gp; Pasini, E; Lettini, Aa; Sacchetti, F; De Conciliis, C; Doglioni, C; Dolcetti, R
Baseline neutrophils and derived neutrophil-to-lymphocyte ratio: prognostic relevance in metastatic melanoma patients receiving ipilimumab
file con accesso da definire2016 Ferrucci, Pf; Ascierto, Pa; Pigozzo, J; Del Vecchio, M; Maio, M; Cappellini, Gca; Guidoboni, M; Queirolo, P; Savoia, P; Mandala, M; Simeone, E; Valpione, S; Altomonte, M; Spagnolo, F; Cocorocchio, E; Gandini, S; Giannarelli, D; Martinoli, C
Cancer Bio-Immunotherapy in Siena": Twelfth Meeting of the Network Italiano per la Bioterapia dei Tumori (NIBIT), Siena, Italy, October 9-11, 2014
file con accesso da definire2016 Maio, M; Bertocci, E; Pilla, L; Fazio, C; Chiarucci, C; Cutaia, O; Fonsatti, E; Maccalli, C; Parmiani, G; Mondino, A; Robbins, Pf; Angelova, M; Stassi, G; Cioffi, M; Cavallo, F; Pellegatta, S; Sangiolo, D; Russo, V; Protti, Mp; Tripodo, C; Marchesi, F; Di Mitri, D; Ferrini, S; Bedognetti, D; Marincola, Fm; Fridman, Wh; Seliger, B; Cappuzzello, E; Moschella, F; Romero, P; Figdor, Cg; Griffiths, Ea; Aurisicchio, L; Weber, J; Calabro', L; Tumori, T; Ibrahim, R; Ferrè, P; Fabre, P; Del Vecchio, M; Tumori, N; Ramazzotti, M; Weide, B; Giannarelli, D; Elena, Tr; Guidoboni, M; Buonaguro, L; Tumori, Cd; Di Giacomo, Am.
Chlamydia infection and lymphomas: Association beyond ocular adnexal lymphomas highlighted by multiple detection methods
file con accesso da definire2008 Ponzoni, M; Ferreri, Ajm; Guidoboni, M; Lettini, Aa; Cangi, Mg; Pasini, E; Sacchi, L; Pecciarini, L; Grassi, S; Dal Cin, E; Stefano, R; Magnino, S; Dolcetti, R; Doglioni C * Equally, Contributed
Combined and sequential expression of p53, Rb, Ras and Bcl-2 in bronchial preneoplastic lesions
file con accesso da definire1997 Ferron, Pe; Bagni, I; Guidoboni, M; Beccati, Md; Nenci, I
Comparative efficacy and safety of targeted therapies for BRAF-mutant unresectable or metastatic melanoma: Results from a systematic literature review and a network meta-analysis
2022 Corrie, P; Meyer, N; Berardi, R; Guidoboni, M; Schlueter, M; Kolovos, S; Macabeo, B; Trouiller, Jb; Laramée, P.
Complementary vaccination protocol with dendritic cells pulsed with autologous tumour lysate in patients with resected stage III or IV melanoma: protocol for a phase II randomised trial (ACDC Adjuvant Trial).
file con accesso da definire2018 Ridolfi, L; de Rosa, F; Fiammenghi, L; Petrini, M; Granato, Am; Ancarani, V; Pancisi, E; Soldati, V; Cassan, S; Bulgarelli, J; Riccobon, A; Gentili, G; Nanni, O; Framarini, M; Tauceri, F; Guidoboni, M
Correspondence re: Samowitz et al., Microsatellite instability in sporadic colon cancer is associated with an improved prognosis at the population level. Cancer Epidemiol. Biomark. Prev., 10 : 917-923, 2001
file con accesso da definire2002 Dolcetti, R; Guidoboni, M; Viel, A; Boiocchi, M
CTLA-4 gene variant -1661A>G may predict the onset of endocrine adverse events in metastatic melanoma patients treated with ipilimumab
file con accesso da definire2018 Queirolo, P; Dozin, B; Morabito, A; Banelli, B; Carosio, R; Fontana, V; Ferrucci, Pf; Martinoli, C; Cocorocchio, E; Ascierto, Pa; Madonna, G; Simeone, E; De Galitiis, F; Antonini Cappellini, Gc; Marchetti, P; Guida, M; Tommasi, S; Ghilardi, L; Merelli, B; Fava, P; Osella-Abate, S; Guidoboni, M; Romani, M; Ferone, D; Spagnolo, F; Pistillo, Mp; Italian Melanoma Intergroup, (IMI)
Dabrafenib-trametinib combination in 'field-practice': an Italian experience
file con accesso da definire2018 Depenni, R; De Rosa, F; Greco, S; Ridolfi, L; Pellacani, G; Ponti, G; Cascinu, S; Guidoboni, M
Dendritic cell vaccination for metastatic melanoma: a 14-year monoinstitutional experience
file con accesso da definire2017 de Rosa, F; Ridolfi, L; Fiammenghi, L; Petrini, M; Granato, Am; Ancarani, V; Pancisi, E; Soldati, V; Cassan, S; Bulgarelli, J; Framarini, M; Tauceri, F; Migliori, G; Brolli, C; Gentili, G; Petracci, E; Nanni, O; Riccobon, A; Ridolfi, R; Guidoboni, M
Dendritic cell-based vaccine in advanced melanoma: update of clinical outcome
file con accesso da definire2011 Ridolfi, L; Petrini, M; Fiammenghi, L; Granato, Am; Ancarani, V; Pancisi, E; Brolli, C; Selva, M; Scarpi, E; Valmorri, L; Nicoletti, Svl; Guidoboni, M; Riccobon, A; Ridolfi, R
Effect of vaccination with autologous tumor-loaded dendritic cells on intratumoral regulatory T cells in metastatic melanoma patients
file con accesso da definire2013 M., Guidoboni; A. M., Granato; V., Ancarani; E., Pancisi; M., Petrini; A., Riccobon; L., Fiammenghi; F., Drago; L., Ridolfi; F., De Rosa; O., Nanni; L., Valmorri; Lanza, Giovanni; L., Serra; G. M., Verdecchia; G., Migliori; D., Amadori; R., Ridolfi
Efficacy and safety of ipilimumab in patients with advanced melanoma and brain metastases
file con accesso da definire2014 Queirolo, P; Spagnolo, F; Ascierto, Pa; Simeone, E; Marchetti, P; Scoppola, A; Del Vecchio, M; Di Guardo, L; Maio, M; Di Giacomo, Am; Antonuzzo, A; Cognetti, F; Ferraresi, V; Ridolfi, L; Guidoboni, M; Guida, M; Pigozzo, J; Sileni, Vc
Efficacy of ipilimumab plus nivolumab or ipilimumab plus fotemustine vs fotemustine in patients with melanoma metastatic to the brain: Primary analysis of the phase III NIBIT-M2 trial
2020 Di Giacomo, Am; Chiarion-Sileni, Vc; Del Vecchio, M; Ferrucci, Pf; Guida, M; Quaglino, P; Guidoboni, M; Marchetti, P; Cutaia, O; Amato, G; Gambale, E; Calabrò, L; Valente, M; Danielli, R; Giannarelli, D; Mandalà, M; Maio, M
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Activation of infiltrating cytotoxic T lymphocytes and lymphoma cell apoptotic rates in gastric MALT lymphomas - Differences between high-grade and low-grade cases | 1999 | Guidoboni, M; Doglioni, C; Laurino, L; Boiocchi, M; Dolcetti, R | file con accesso da definire |
| Anti-PD1 antibodies in patients aged ≥ 75 years with metastatic melanoma: A retrospective multicentre study | 2020 | Ridolfi, L; de Rosa, F; Petracci, E; Tanda, Et; Marra, E; Pigozzo, J; Marconcini, R; Guida, M; Ca...ppellini, Gca; Gallizzi, G; Occelli, M; Pala, L; Gambale, E; Bersanelli, M; Galdo, G; Cortellini, A; Morgese, F; Zoratto, F; Stucci, Ls; Strippoli, S; Guidoboni, M | |
| Appropriate use of tumour biomarkers for treatment with innovative drugs: A retrospective study | 2016 | Massa, I; Nanni, O; Guidoboni, M; Frassineti, Gl; Rocca, A; Burgio, Ma; Valmorri, L; Marri, M; Pi...ancastelli, A; Faedi, M; Leoni, M; Tamberi, S; Altini, M; Amadori, D | file con accesso da definire |
| Association between Helicobacter pylori infection and MALT-type lymphoma of the ocular adnexa: clinical and therapeutic implications | 2006 | Ferreri, Aj; Ponzoni, M; Viale, E; Guidoboni, M; De Conciliis, C; Resti, Ag; Politi, L; Lettini, ...Aa; Sacchetti, F; Dognini, G; Dolcetti, R; Doglioni, C | file con accesso da definire |
| Association of CTLA-4 Gene Variants with Response to Therapy and Long-term Survival in Metastatic Melanoma Patients Treated with Ipilimumab: An Italian Melanoma Intergroup Study | 2017 | Queirolo, P; Dozin, B; Morabito, A; Banelli, B; Piccioli, P; Fava, C; Leo, C; Carosio, R; Laurent..., S; Fontana, V; Ferrucci, Pf; Martinoli, C; Cocorocchio, E; Battaglia, A; Ascierto, Pa; Capone, M; Simeone, E; De Galitiis, F; Pagani, E; Cappellini, Gca; Marchetti, P; Guida, M; Tommasi, S; Mandala, M; Merelli, B; Quaglino, P; Fava, P; Guidoboni, M; Romani, M; Spagnolo, F; Pistillo, Mp | file con accesso da definire |
| Bacteria-eradicating therapy with doxycycline in ocular adnexal MALT lymphoma: A multicenter prospective trial | 2006 | Ferreri, Ajm; Ponzoni, M; Guidoboni, M; Resti, Ag; Politi, Ls; Cortelazzo, S; Demeter, J; Zallio,... F; Palmas, A; Muti, G; Dognini, Gp; Pasini, E; Lettini, Aa; Sacchetti, F; De Conciliis, C; Doglioni, C; Dolcetti, R | file con accesso da definire |
| Baseline neutrophils and derived neutrophil-to-lymphocyte ratio: prognostic relevance in metastatic melanoma patients receiving ipilimumab | 2016 | Ferrucci, Pf; Ascierto, Pa; Pigozzo, J; Del Vecchio, M; Maio, M; Cappellini, Gca; Guidoboni, M; Q...ueirolo, P; Savoia, P; Mandala, M; Simeone, E; Valpione, S; Altomonte, M; Spagnolo, F; Cocorocchio, E; Gandini, S; Giannarelli, D; Martinoli, C | file con accesso da definire |
| Cancer Bio-Immunotherapy in Siena": Twelfth Meeting of the Network Italiano per la Bioterapia dei Tumori (NIBIT), Siena, Italy, October 9-11, 2014 | 2016 | Maio, M; Bertocci, E; Pilla, L; Fazio, C; Chiarucci, C; Cutaia, O; Fonsatti, E; Maccalli, C; Parm...iani, G; Mondino, A; Robbins, Pf; Angelova, M; Stassi, G; Cioffi, M; Cavallo, F; Pellegatta, S; Sangiolo, D; Russo, V; Protti, Mp; Tripodo, C; Marchesi, F; Di Mitri, D; Ferrini, S; Bedognetti, D; Marincola, Fm; Fridman, Wh; Seliger, B; Cappuzzello, E; Moschella, F; Romero, P; Figdor, Cg; Griffiths, Ea; Aurisicchio, L; Weber, J; Calabro', L; Tumori, T; Ibrahim, R; Ferrè, P; Fabre, P; Del Vecchio, M; Tumori, N; Ramazzotti, M; Weide, B; Giannarelli, D; Elena, Tr; Guidoboni, M; Buonaguro, L; Tumori, Cd; Di Giacomo, Am. | file con accesso da definire |
| Chlamydia infection and lymphomas: Association beyond ocular adnexal lymphomas highlighted by multiple detection methods | 2008 |
Ponzoni, M; Ferreri, Ajm; Guidoboni, M; Lettini, Aa; Cangi, Mg; Pasini, E; Sacchi, L; Pecciarini,... L; Grassi, S; Dal Cin, E; Stefano, R; Magnino, S; Dolcetti, R; Doglioni C * Equally, Contributed |
file con accesso da definire |
| Combined and sequential expression of p53, Rb, Ras and Bcl-2 in bronchial preneoplastic lesions | 1997 | Ferron, Pe; Bagni, I; Guidoboni, M; Beccati, Md; Nenci, I | file con accesso da definire |
| Comparative efficacy and safety of targeted therapies for BRAF-mutant unresectable or metastatic melanoma: Results from a systematic literature review and a network meta-analysis | 2022 | Corrie, P; Meyer, N; Berardi, R; Guidoboni, M; Schlueter, M; Kolovos, S; Macabeo, B; Trouiller, J...b; Laramée, P. | |
| Complementary vaccination protocol with dendritic cells pulsed with autologous tumour lysate in patients with resected stage III or IV melanoma: protocol for a phase II randomised trial (ACDC Adjuvant Trial). | 2018 | Ridolfi, L; de Rosa, F; Fiammenghi, L; Petrini, M; Granato, Am; Ancarani, V; Pancisi, E; Soldati,... V; Cassan, S; Bulgarelli, J; Riccobon, A; Gentili, G; Nanni, O; Framarini, M; Tauceri, F; Guidoboni, M | file con accesso da definire |
| Correspondence re: Samowitz et al., Microsatellite instability in sporadic colon cancer is associated with an improved prognosis at the population level. Cancer Epidemiol. Biomark. Prev., 10 : 917-923, 2001 | 2002 | Dolcetti, R; Guidoboni, M; Viel, A; Boiocchi, M | file con accesso da definire |
| CTLA-4 gene variant -1661A>G may predict the onset of endocrine adverse events in metastatic melanoma patients treated with ipilimumab | 2018 | Queirolo, P; Dozin, B; Morabito, A; Banelli, B; Carosio, R; Fontana, V; Ferrucci, Pf; Martinoli, ...C; Cocorocchio, E; Ascierto, Pa; Madonna, G; Simeone, E; De Galitiis, F; Antonini Cappellini, Gc; Marchetti, P; Guida, M; Tommasi, S; Ghilardi, L; Merelli, B; Fava, P; Osella-Abate, S; Guidoboni, M; Romani, M; Ferone, D; Spagnolo, F; Pistillo, Mp; Italian Melanoma Intergroup, (IMI) | file con accesso da definire |
| Dabrafenib-trametinib combination in 'field-practice': an Italian experience | 2018 | Depenni, R; De Rosa, F; Greco, S; Ridolfi, L; Pellacani, G; Ponti, G; Cascinu, S; Guidoboni, M | file con accesso da definire |
| Dendritic cell vaccination for metastatic melanoma: a 14-year monoinstitutional experience | 2017 | de Rosa, F; Ridolfi, L; Fiammenghi, L; Petrini, M; Granato, Am; Ancarani, V; Pancisi, E; Soldati,... V; Cassan, S; Bulgarelli, J; Framarini, M; Tauceri, F; Migliori, G; Brolli, C; Gentili, G; Petracci, E; Nanni, O; Riccobon, A; Ridolfi, R; Guidoboni, M | file con accesso da definire |
| Dendritic cell-based vaccine in advanced melanoma: update of clinical outcome | 2011 | Ridolfi, L; Petrini, M; Fiammenghi, L; Granato, Am; Ancarani, V; Pancisi, E; Brolli, C; Selva, M;... Scarpi, E; Valmorri, L; Nicoletti, Svl; Guidoboni, M; Riccobon, A; Ridolfi, R | file con accesso da definire |
| Effect of vaccination with autologous tumor-loaded dendritic cells on intratumoral regulatory T cells in metastatic melanoma patients | 2013 | M., Guidoboni; A. M., Granato; V., Ancarani; E., Pancisi; M., Petrini; A., Riccobon; L., Fiammeng...hi; F., Drago; L., Ridolfi; F., De Rosa; O., Nanni; L., Valmorri; Lanza, Giovanni; L., Serra; G. M., Verdecchia; G., Migliori; D., Amadori; R., Ridolfi | file con accesso da definire |
| Efficacy and safety of ipilimumab in patients with advanced melanoma and brain metastases | 2014 | Queirolo, P; Spagnolo, F; Ascierto, Pa; Simeone, E; Marchetti, P; Scoppola, A; Del Vecchio, M; Di... Guardo, L; Maio, M; Di Giacomo, Am; Antonuzzo, A; Cognetti, F; Ferraresi, V; Ridolfi, L; Guidoboni, M; Guida, M; Pigozzo, J; Sileni, Vc | file con accesso da definire |
| Efficacy of ipilimumab plus nivolumab or ipilimumab plus fotemustine vs fotemustine in patients with melanoma metastatic to the brain: Primary analysis of the phase III NIBIT-M2 trial | 2020 | Di Giacomo, Am; Chiarion-Sileni, Vc; Del Vecchio, M; Ferrucci, Pf; Guida, M; Quaglino, P; Guidobo...ni, M; Marchetti, P; Cutaia, O; Amato, G; Gambale, E; Calabrò, L; Valente, M; Danielli, R; Giannarelli, D; Mandalà, M; Maio, M |